Mohammed M. DAR,Joyson J. KARAKUNNEL,Haiyi JIANG,Maxwell J. KIRKBY
申请号：
US15568586
公开号：
US20180147279A1
申请日:
2016.04.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and a tyrosine kinase inhibitor in a subject identified as having an EGFR mutation-positive tumor.
